TriMark Publications Research

TriMark Publications is a premium market-research and publishing company providing original reports in the biotechnology, medical device, diagnostic and healthcare segments. Clients benefit from an expert, objective source for their research needs, saving time and resources.

TriMark Publications' reports are wide-ranging research publications that explore development activity, recent advances, and emerging trends in health care markets. In addition to our in-house proprietary database, the TriMark staff seeks out experts in the field, conducting extensive secondary research, and develops the findings into a cohesive, well-documented written analysis. Their specialty is constant staff review of reports to continually add and revise so that each report is absolutely up to date.

TriMark Publications Research
 

List of reports from TriMark Publications Research

< prev 1    3  
Diabetes, Metabolic Syndrome and Cardiovascular Disease
1/1/2016 | published by: TriMark Publications
... primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes among ...  |  read more...
USD 5,500
High-Growth Diagnostic Testing Markets
1/1/2016 | published by: TriMark Publications
... clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphasis in this TriMark Publications report is on those companies that are actively developing and marketing high-growth ...  |  read more...
USD 5,500
Cancer Bundle
1/1/2016 | published by: TriMark Publications
... Diagnostic Testing World Markets. Cancer Therapeutics Markets. Cancer Vaccines Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Game Changers in Breast Cancer Therapies. Molecular Diagnostics in Cancer Testing. ...  |  read more...
USD 85,500
Cancer Diagnostic Testing World Markets
1/1/2016 | published by: TriMark Publications
... million Americans have or have had some form of cancer. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, ...  |  read more...
USD 5,500
Diagnostics Bundle
9/1/2015 | published by: TriMark Publications
... Diagnostics in Personalized Medicine and Cancer Therapy. European Point of Care Diagnostic Testing Markets. High-Growth Diagnostic Testing Markets. Key Diagnostic Testing Markets. Molecular Diagnostics in Cancer Testing. Molecular Diagnostics in Genetic Testing. Molecular Diagnostics in ...  |  read more...
USD 39,950
Molecular Diagnostics Bundle
9/1/2015 | published by: TriMark Publications
... the following TriMark Publications reports at a 15% discount off the individual reports being purchased separately: Molecular Diagnostics in Cancer Testing. Molecular Diagnostics in Genetic Testing. Molecular Diagnostics in Infectious Disease Testing. Molecular Diagnostics Markets.  |  read more...
USD 11,050
Companion Diagnostics in Personalized Medicine and Cancer Therapy
9/1/2015 | published by: TriMark Publications
... be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded ...  |  read more...
USD 4,000
Blood Glucose Testing and Diabetes Management
9/1/2015 | published by: TriMark Publications
... primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly ...  |  read more...
USD 4,000
Molecular Diagnostics in Cancer Testing
8/1/2015 | published by: TriMark Publications
... first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for ...  |  read more...
USD 4,000
Molecular Diagnostics in Infectious Disease Testing
5/1/2015 | published by: TriMark Publications
... molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in ...  |  read more...
USD 4,000
Point of Care Diagnostic Testing World Markets
3/1/2015 | published by: TriMark Publications
... immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs ...  |  read more...
USD 4,000
IVD (In Vitro Diagnostic) Testing World Markets
1/1/2015 | published by: TriMark Publications
... interest in the genomics testing. Recent advances in molecular diagnostics technologies--including sequencing, PCR and microarray--are enabling greater sensitivity and precision in nucleic acid measurements, further expanding manufacturers’ offerings. This TriMark Publications report is an overview ...  |  read more...
USD 4,000
Cardiac Marker Diagnostic Testing Markets
1/1/2015 | published by: TriMark Publications
... cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of ...  |  read more...
USD 4,000
U.S. Glucose Testing Markets
7/1/2014 | published by: TriMark Publications
... industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. Direct access testing has ...  |  read more...
USD 4,000
World Glucose Self-Testing Markets
7/1/2014 | published by: TriMark Publications
... glucose self-testing products is undergoing a significant transition driven by the advent of new analytical technologies and new recommendations for tight glucose control for monitoring diabetes. In addition, the proliferation of the middle class within ...  |  read more...
USD 4,000
Disposable Medical Supplies Markets
7/1/2014 | published by: TriMark Publications
... global healthcare equipment and supplies sector. The disposable medical supplies include: conventional syringes with needles, prefilled syringes, disposable medical catheters, wound care products, isolation gowns, surgical drapes, facemasks, medical gloves, adult incontinence products, blood glucose ...  |  read more...
USD 2,500
Medical Devices Bundle
7/1/2014 | published by: TriMark Publications
... separately: Cardiac Rhythm Management Devices World Markets. Catheter Markets. Disposable Medical Supplies Markets. Disposable Syringe Markets. Home Medical Testing Devices. Orthopedics Markets. Patient Monitoring Markets. Plastic Surgery Markets. Respiratory Therapeutics and Devices Markets. Sleep Disorders.  |  read more...
USD 21,250
Hemoglobin A1c Testing Markets
7/1/2014 | published by: TriMark Publications
... than 366 million diabetics worldwide, hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued ...  |  read more...
USD 4,000
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
7/1/2014 | published by: TriMark Publications
... early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for ...  |  read more...
USD 2,500
Veterinary Health Markets
6/1/2014 | published by: TriMark Publications
... products continues to expand, encompassing anti-infectives, parasite controls, reproductive aids, metabolic drugs, feed additives, antibiotics, vaccines, topical solutions and imaging diagnostics as well as novel treatments for chronic conditions such as osteoarthritis, cardiovascular disease and ...  |  read more...
USD 2,500
Global Flow Cytometry Market
5/1/2014 | published by: TriMark Publications
... global flow cytometry market remains one of the fastest-growing segments of life sciences and clinical diagnostics markets. In the current life sciences research, pharmaceutical drug discovery and development, and clinical diagnostics markets, flow cytometry offers ...  |  read more...
USD 2,500
DNA Sequencing and PCR Markets
11/1/2013 | published by: TriMark Publications
... competitive, driven by rapid technological advancements and aggressive price wars. Next-generation sequencing presents an exciting area of growth for life science tool vendors, including those providing sequencers, ancillary instrumentation, reagents and software. This TriMark Publications ...  |  read more...
USD 2,500
Genetics Bundle
11/1/2013 | published by: TriMark Publications
... PCR Markets. Gene Expression Reagents Markets. Genomics World Markets. Microarray Markets. Molecular Diagnostics in Genetic Testing. Personalized Medicine. Pharmacogenomics for Clinical Use and in Drug Development. Regenerative Medicine Markets. RNA Interference Markets. Stem Cell Markets.  |  read more...
USD 23,375
Drugs of Abuse Testing Markets
11/1/2013 | published by: TriMark Publications
... abuse testing offers promise for significant growth and innovation. Examined in this study are assays for alcohol, cannabinoids, cocaine, amphetamines, opiates and phencyclidine, as well as assays for addictive prescription drugs such as OxyContin. Moreover, ...  |  read more...
USD 2,500
Molecular Diagnostics in Genetic Testing
11/1/2013 | published by: TriMark Publications
... microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment. Major developments include the integration of specialty labs and gene expression profiling into clinical practice, the ...  |  read more...
USD 2,500
< prev 1    3  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!